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Objectives. The aim of this study was to quantify total collagen 
and the type I/type III collagen ratio and their localization in 
hearts with dilated cardiomyopathy. 
Background. Patients with dilated cardiomyopathy ave an 
increase in intramyocardial fibrillar collagen. Types I and III are 
the main constituents and have different physical properties that 
may affect cardiac compliance. 
Methods. Nineteen hearts with dilated cardiomyopathy were 
studied (17 cardiac explants, 2 hearts obtained at autopsy) and 
compared with reference hearts. Total collagen was determined by 
hydroxyproline analysis. Collagen types I and III were analyzed 
using the cyanogen bromide method and immunnhistochemical 
analysis followed by microdensitophotometric quantification. Lo- 
calization of collagen types I and IlI was established at the light 
and electron microscopic levels. Immunoelectron microscopy pro- 
vided information regarding their localization. 
Results. Total collagen and the collagen type I/type III ratio 
were increased in hearts with dilated cardiomyopathy (p < 0.05). 
Electron microscopy showed a diffuse increase in collagen fibrils 
in the endomysium; the perimysium showed an inhomogeneous 
increase. Collagen fibrils were thicker, and fibrous long-spacing 
collagen occurred in the endomysium. Immunoelectron micro- 
scopic findings confirmed an increase in type 1 collagen. 
Conclusions. Hearts with dilated cardiomyopathy ave a statis- 
tically significant increase in the collagen type I/type II1 ratio. The 
changes occur in the endomysium and perimysium, although with 
differences in distribution. These changes in intramyocardiai 
collagen may be clinically relevant because they may affect cardiac 
rigidity and, therefore, eventually may render the heart less 
compliant. Further studies are needed to evaluate at what point in 
the course of the disease these changes appear. 
(J Am Coll Cardiol 1995;25:1263-72) 
Dilated cardiomyopathy is a heart muscle disease of unknown 
etiology characterized pathophysiologically b  a decrease in 
contractility that eventually may lead to chronic congestive 
heart failure. Hearts with dilated cardiomyopathy show an 
overall increase in intramyocardial fibrillar collagen compared 
with that in reference hearts (1-3). The myocardial collagen 
network mainly consists of types I and III collagen, which have 
different physical properties. Type I collagen mainly provides 
rigidity, whereas type III collagen contributes to elasticity. 
Bishop et al. (4) recently reported an increase in the percent of 
type I collagen in hearts with chronic congestive heart failure. 
Such remodeling may be relevant clinically because collagens 
play a key role in maintaining myocardial integrity and affect 
cardiac compliance (5). 
Understanding the mechanisms of collagen augmentation, 
therefore, may lead to new therapeutic strategies. Hence, the 
quantification of the type I/type II1 collagen ratio is important 
to provide a firm scientific background for such a concept. 
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Moreover, there is still inadequate information with respect o 
the topographic distribution of types I and III collagen and 
changes in their ratio. Light microscopic studies (1,3) have 
provided information regarding the localization of collagens 
but do not reveal the exact distribution of types I and III 
collagen at the level of the endomysium and perimysium. Ultra- 
structural studies could fill this need. 
The present study was designed to quantify total collagen 
content in hearts with dilated cardiomyopathy compared with 
that in reference hearts, to quantify the type I/type III collagen 
ratio biochemically and immunohistochemically nd to deter- 
mine the tissue localization of types I and III collagen at the 
light and electron microscopic levels. 
Methods  
Heart specimens. The hearts studied were obtained from 
19 patients (6 women, 13 men', mean age 48 years, range 15 to 
60), with dilated (idiopathic) cardiomyopathy, clinically all in 
New York Heart Association functional classes IV and V, and 
were collected as cardiac explants (n = 17) or at autopsy (n : 
2). The hearts obtained at autopsy all became available within 
10 h after death. Hearts from 16 age-matched a ult patients (8 
women, 8 men; mean of 52 years) who died of noncardiovas- 
cular-related isease served as the reference group. Despite 
mild atherosclerotic disease revealed at autopsy, none of the 
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hearts howed evidence of recent or scarred myocardial infarc- 
tion. None of the patients had had systemic hypertension. 
In each instance, a cross section of the heart was taken 
perpendicular to the left ventricular long axis, just below the 
level of the base of the papillary muscles. Transmural samples 
from the left lateral ventricular wall were used. The tissue 
blocks were snap-frozen in isopentane and cooled in liquid 
nitrogen. For the ultrastructural studies, samples were fixed in 
Karnovsky's fixative. 
Biochemical analysis. Hydro.9,proline method. The total 
amount of collagen in each heart specimen was determined by 
establishing the level of hydroxyproline. Cryostat sections were 
cut at 20-/~m thickness and collected in a cold Eppendorf test 
tube, and the exact wet weight of the tissue was determined. 
Total collagen concentration was determined by measuring the 
hydroxyproline l vels according to the method of Stegemann 
and Stalder (6) and expressed as t~g collagen/rag wet weight of 
tissue. 
Cyanogen bromide analysis. A number of the heart speci- 
mens were also used for cyanogen bromide analysis (15 hearts 
with dilated cardiomyopathy, 10 reference hearts). Cryostat 
sections were cut at 20-p~m thickness, collected in Eppendorf 
test tubes and treated with 2% sodium dodecyl sulfate in 0.1 
mol/liter Tris HCI buffer (pH 7.2) for 24 h at room tempera- 
ture. The homogenates were centrifuged at 4,000 rpm for 
10 rain. The pellet was resuspended in 250 p.l of 70% vol/vol of 
formic acid and 5 ~1 of cyanogen bromide (stock solution 100 
/zg//zl). The digestion time was 24 h under mixing conditions at 
30°C. The residue was vacuum dried. The resulting peptides 
were separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS PAGE). For reference purposes, types I
and III collagen standards were prepared from human leiomy- 
oma tissue, as described by ChandraRajan (7). When gel 
electrophoresis was completed, the gel was stained for 30 rain 
by gentle shaking in an aqueous olution containing 0.125% 
Coomassie blue R250, 50% methanol and 1{)% acetic acid. The 
gel was destained by continuous shaking using a solution of 
10% acetic acid and 50% methanol in distilled water. Gels 
were scanned using an LKB laser spectrophotometer, andthe 
peak areas were calculated by computerized integration. The 
al(III) CB3.6.8 peptide was used to quantitate type III colla- 
gen (8). This was calculated as follows: 
% Type III = 
Area al(llI) CB3.6.8 × 100 
% Area type Ill standard × Total area ll peaks 
The results were expressed as the type I/type III collagen ratio. 
Immunohistochemical analysis. Consecutive cryostat sec- 
tions of the tissue specimens, as previously described, were 
used for immunoenzyme double staining for types I and III 
collagen. The monoclonal mouse anti-type I collagen and 
mouse anti-type 1II collagen (clone I-8H5, immunoglobulin 
G2a and clone III-53, immunoglobulin G1, respectively; both 
gifts of Dr. K. Iwata, Fuji Chemical Industries Ltd., Toyama, 
Japan). The optimal dilution of both antibodies was 1:10, and 
antibody titration was performed on human leiomyoma tissue 
with a known type 1/type III collagen ratio (9). The double- 
staining protocol according to Van der Loos et al. (10) was 
based on the different subclasses of the antibodies. 
Microdensitophotometric quantification. Cryostat sections 
were cut at 6->m thickness and mounted on organosilane- 
coated glass slides, dried overnight at room temperature and 
fixed in cold acetone (10 min, 4°C). 
Types I and III collagen were immunostained with the same 
mouse anti-type I collagen and mouse anti-type III collagen 
(see Immunohistochemical analysis). The method applied was 
a two-step indirect immunoalkaline phosphatase t chnique. 
The end product was visualized with fast red, and types I and 
III collagen were quantified with a microdensitophotometer at 
a wavelength of 500 nm (11). Leiomyoma tissue, documented 
to have a type I/type III collagen ratio of -1 (9), was used to 
establish the appropriate dilutions of the anticollagen antibod- 
ies to achieve identical optical densities. Cyanogen bromide 
analysis of the leiomyoma tissue used confirmed this ratio. 
Leiomyoma tissue sections erved as a reference during every 
staining procedure. Types I and III collagen were measured in
the whole sections, excluding perivascular cuffs, and the results 
were expressed as the type I/type Ill collagen ratio. 
Ultrastruetural analysis. Electron microscopic studies. For 
the ultrastructural studies, five cardiac explants, one heart 
obtained at autopsy and six adult reference hearts were used. 
Samples from the left ventricular lateral wall, adjacent to 
the samples used for freezing, were fixed in Karnovsky's 
fixative, postfixed in 1% osmium tetroxide, dehydrated in
2,2-dimethoxypropane (12) and embedded in epon. Ultrathin 
sections were treated briefly with tannic acid to stain extracel- 
lular elements (13), followed by uranyl acetate and lead citrate. 
For immunoelectron microscopy studies, adjacent tissue sam- 
ples were fixed in freshly prepared 4% paraformaldehyde in 
0.1 tool/liter of cacodylate buffer (pH 7.2) for a maximum of 
72 h at 4°C. They were dehydrated in ethanol (according to the 
PLT technique Lowicryl) and embedded in LR gold resin at 
-20°C (14). Polymerization was done for 24 h at -20°C 
followed by 48 to 72 h at room temperature under ultraviolet 
light. For single-staining procedures, thin sections were cut and 
mounted on formvar-coated copper grids (50 mesh). For 
double-labeling procedures, uncoated gold grids (150 mesh, 
hexagonal) were used. The sections were stained with uranyl 
acetate and lead citrate. 
Collagen fibril morphology in the endomysium and perimy- 
slum was studied in six hearts with dilated cardiomyopathy and 
six reference hearts using conventional electron microscopy. 
As a first step, the grids were screened for groups of collagen 
fibrils in the endomysium and perimysium at low magnification 
(×5,000). Their precise localization in the grids initially was 
stored in the computer, and after completion of the screening 
procedure all sites were restudied, and the circumferences of
the collagen fibrils were analyzed at a magnification of400,000. 
To obtain reliable statistical analysis, a minimum of 200 
cross-sectioned fibrils/grid were randomly selected, measured 
and analyzed. The software (15) was developed by the Tech- 
nical University (Delft, The Netherlands) and retailed by 
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Figure 1. Densitometric scans (right) and the corresponding gelelec- 
trophoresis (left) of cyanogen bromide peptides obtained from (A) 
purified type I collagen obtained from human leiomyoma tissue, (B) 
purified type III collagen obtained from human leiomyoma tissue, (C) a 
mixture of types I and III (A + B) in a ratio 1:1. (D) A heart with dilated 
cardiomyopathy and (E) a reference heart. The arrows indicate the 
al(III) CB3.6.8 peptide used to quantitate type III collagen. 
DIFA, Breda, The Netherlands. The hardware, developed by 
DIFA, was a 486-D 33-mHz computer with a frame grabber 
from Visionlog VS 100 (Imaging Technology). The electron 
microscope used was a Philips CM 10 with a GATAN Fiber 
Optic Coupled model 622 camera nd a TV control unit model 
622-0600. Calibration was performed with a grid from Agar 
Scientific (model S108, 2,160 lines/ram cross-ruled grating). 
lmmunoelectron microscopic studies. For single-staining 
procedures, the tissue sections were incubated for 15 rain on a 
droplet of 0.1% sodium borohydride in phosphate-buffered 
saline (PBS), rinsed in PBS and transferred toa droplet of 0.1 
tool/liter of PBS containing 10% normal human serum (Cen- 
tral Laboratory for Blood Transfusion, Amsterdam, The Neth- 
erlands) and 0.2% acetylated bovine serum albumin (BSA) 
(Aurion, Wageningen, The Netherlands) and incubated for 
15 rain. The sections were transferred to a droplet of the 
primary antibody (diluted in PBS [see later]) and incubated for 
2 h at room temperature. The grids were rinsed in PBS/normal 
human serum (NHS)/BSA-C (5 x 5 rain). Then the secondary 
antibody was applied (diluted in PBS/NHS/BSA-C [see later]) 
for 30 rain. After rinsing in the same solution, the sections were 
incubated with the gold-labeled antibody (diluted in PBS/NHS/ 
BSA-C containing 0.1% Tween) for 30 rain at room tempera- 
ture. 
After rinsing thoroughly with distilled water, the sections 
were dried. Staining with uranyl acetate and lead citrate was 
performed before examination with a Philips CM 10 electron 
microscope. 
The optimal dilutions for the primary polyclonal goat 
antibodies were 1:25 for type I collagen and 1:400 for type III 
collagen (Southern Biotechnology Associates). Antibody titra- 
tion for both antibodies was performed on human leiomyoma 
tissue, with a known type I/type III collagen ratio (see Micro- 
densitophotometric analysis). The rabbit anti-goat antibody 
was used at a dilution of 1:800 (Dako, Glostrup, Denmark), the 
goat anti-rabbit/15-nm gold at 1:50 (Amersham, United King- 
dom). 
For double-staining procedures, the technique followed was 
that described by Bendayan (16). Sections were mounted on 
uncoated grids, which allows both sides to be used for immu- 
nohistochemical nalysis. This is particularly useful if the 
primary antibodies are of the same species. The first primary 
antibody (type I collagen) was applied to one side of the grid, 
and the second primary antibody (type III collagen) was 
applied to the other side. After completion of both incuba- 
tions, the sections were dried. Thereafter, the grids were 
coated with Formvar on the side where the sections were 
mounted on the grids, thus preventing excess beam damage to 
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Table 1. Percent of Collagen Type III and Ratio of Type I to 
Type II1 Collagen, Quantified by Cyanogen Bromide Analysis 
Diagnosis 
Type III 
Collagen Type I/Type III 
(%) Collagen Ratio 
Reference hearts 
1 58.0 0.72 
2 61.1 0.64 
3 60.3 0.66 
4 52.9 0.89 
5 64.2 0.56 
6 67.8 0.47 
7 74.2 0.35 
8 63.7 0.54 
9 63.2 0.58 
10 62.2 0.61 
Mean 0.60 
SD 0.14 
Hearts with DCM 
1 34.0 1.94 
2 50.3 0.99 
3 47.5 1.11 
4 36.9 1.44 
5 54.2 0.85 
6 34.5 1.54 
7 58.9 0.70 
8 56.4 0.77 
9 61.7 0.62 
10 38.4 1.82 
11 52.0 0.92 
12 33.1 2.02 
13 36.4 1.70 
14 39.0 1.56 
15 46.7 1.14 
Mean 1.27 
SD 0.47 
DCM - dilated cardiomyopathy. 
the sections. After staining with uranyl acetate and lead citrate, 
the sections were examined under the electron microscope. 
In most experiments, 15-nm gold was used for type I 
collagen and 30-nm gold for type III collagen. To validate the 
results obtained with gold labeling, control experiments were 
performed inwhich the size of the gold-labeled antibodies was 
reversed (i.e., 30-nm gold for type III collagen and 15-nm gold 
for type I collagen). 
Statistical methods. The results were analyzed statistically 
using the Student t test. 
Resu l ts  
Biochemical analysis. Hydroxyproline method. Adult refer- 
ence hearts had a mean value of 5.7 ~g collagen/mg wet weight 
of tissue (SD 0.89) in the left ventricle. In hearts with dilated 
cardiomyopathy, the concentration of collagen in the left 
ventricle was 12.4 p,g/mg wet weight (SD 4.8). The difference 
between collagen concentrations was statistically significant 
(p < 0.05). There was no correlation between collagen con- 
centration and age or gender of the patients (data not shown). 
Cyanogen bromide analysis. The densitometric s ans of the 
cyanogen bromide-derived peptides for standard collagens 
and for collagens derived from heart issue after electrophore- 
sis are shown in Figure 1. Table 1 shows the calculated 
percentages of type III collagen and the type I/type III collagen 
ratio. In reference hearts the mean type I/type III collagen 
ratio was 0.60 (SD 0.14). In hearts with dilated cardiomyopa- 
thy, this ratio was 1.27 (SD 0.47), which showed an increase in 
the relative proportion of type I versus type III collagen. The 
mean type I/type III collagen ratio was significantly increased 
in hearts with dilated cardiomyopathy compared with that in 
reference hearts (p < 0.05). 
Immnnohistochemical analysis. Reference hearts howed 
a fine, evenly distributed meshwork of collagen in the endo- 
mysium and perimysium. Hearts with dilated cardiomyopathy 
showed an overall increase in staining intensity for both types 
I and type III collagen but with an uneven distribution. Indeed, 
nearly normal areas alternated with parts showing a distinct 
but focal increase in collagen. There was no myocyte necrosis 
in these areas. Double staining for both collagen types revealed 
that the latter areas howed a more intense staining for type I
than type III collagen (Fig. 2). 
Microdensitophotometric analysis. The results of the quan- 
tification of types I and III collagen are summarized in Table 
2. In reference hearts the mean value of the corrected type 
I/type III collagen ratio was 0.54 (SD 0.11). In hearts with 
dilated cardiomyopathy this ratio was 0.89 (SD 0.20). The 
difference between hearts with dilated cardiomyopathy and 
reference hearts had statistical significance (p < 0.05). 
Ultrastructnral nalysis. Electron microscopic studies. In 
line with light microscopic observations, it appeared that the 
density of collagen fibrils in hearts with dilated cardiomyopa- 
thy was increased compared with that in reference hearts. 
Hearts with dilated cardiomyopathy showed a broadened 
endomysium that consisted of a dense meshwork of collagen 
fibrils surrounding individual myocytes. The perimysium also 
showed an increase in density of collagen fibrils. The endomy- 
sial collagen increase showed a diffuse pattern, whereas that of 
the perimysium showed an inhomogeneous increase. 
In reference hearts, the collagen fibrils were relatively thin 
(Fig. 3A, Table 3). In hearts with dilated cardiomyopathy, the 
fibrils presented a range of circumferences with thin and thick 
fibrils mixed together but with a distinct increase in the number 
of thick fibrils (Fig. 3B, Table 3). The difference between 
reference hearts and hearts with dilated cardiomyopathy was 
statistically significant (p < 0.01) (Table 3). 
Fibrous long-spacing collagen with a periodicity of 70 to 
105 nm was seen in both dilated cardiomyopathy and reference 
hearts. In reference hearts the fibrous long-spacing collagen 
was located mainly around blood vessels, but in hearts with 
dilated cardiomyopathy the fibrous long-spacing collagen was 
seen also in the endomysium surrounding individual myocytes 
(Fig. 4). 
Immunoelectron microscopic studies. Reference hearts ap- 
peared to have more type III than type I collagen in both 
endomysium and perimysium (Fig. 5, A and B). In hearts with 
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dilated cardiomyopathy, the immunolabeling revealed adiffuse 
endomysial increase in both collagen types (Fig. 5, C and D). 
Double-staining techniques revealed that the increase was 
more pronounced for type I than type lII collagen (Fig. 6). In 
the perimysium of hearts with dilated cardiomyopathy, there 
was an inhomogeneous increase in both collagen types, with 
focal dense aggregates consisting predominantly of type I 
collagen. There was no difference in staining pattern whether 
the primary antibody was immunostained with 15- or 30-rim 
gold label. 
Discussion 
The collagen meshwork of the myocardium consists of three 
parts: 1) the endomysium, a meshwork of collagen fibers that 
surround individual myocytes; 2) the perimysium, composed of 
coiled collagen fibers that surround groups of myocytes; and 
3) the epimysium, comprising collagen fibers that enwrap 
myocardial cells grouped by the perimysium (17). This ar- 
rangement of intramyocardial fibrillar collagen is considered 
important in maintaining myocardial compliance (5). The 
collagen matrix of normal hearts consists mainly of fibrillar 
types I and III collagen that both colocalize in the myocardium 
(18) but possess different physical properties. Collagen type I 
Figure 2. Immunoenzyrne double staining for collagen type I (blue) 
and type IIl (red) in a normal heart (left) and a heart with dilated 
cardiomyopathy (right). The heart with dilated eardiomyopathy s ows 
hypertrophy of the myocytes and an increase in endomysial nd 
perimysial collagens. ×56, reduced by 27%. 
has a higher tensile strength than collagen type III. Hence, it is 
not only the total amount of intramyocardial collagen that is 
functionally important, but also the relative proportion of both 
types. 
It has indeed been suggested that alterations in this colla- 
gen framework play an important role in ventricular dys- 
function of isehemic and nonischemic origin (19,20). Recent 
studies have shown that in the failing heart the amount of 
collagenous proteins is increased (3,4) and that changes in the 
composition, with regard to the different collagen types and 
rearrangement of the collagen matrix, may have an impact on 
diastolic function (21-23). 
Light mieroseopie analysis. To our knowledge, the present 
study is the first in which types I and III collagen have been 
visualized and simultaneously quantified in hearts of patients 
with end-stage dilated cardiomyopathy and the results com- 
pared with those in reference hearts. For this purpose cryostat 
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Table 2. Type I/Type III Collagen Ratio Quantified Spectrophotometrically in Reference Hearts and 
Hearts with Dilated Cardiomyopathy, Together With Mean Value for Types I and III Collagen in 
Each Section and Type I/Type III Collagen Ratio in Leiomyoma Tissue, Which Served as Reference, 
and Corrected Type I/Type III Collagen Ratio 
Type I Type Ill Reference Type I/Type III 
Type I/Type lII Collagen Collagen Type I/Type III Collagen 
Diagnosis Collagen Ratio (mean value) (mean value) Collagen Ratio Corrected Ratio 
Reference hearts 
1 0.44 17.09 38.58 0.97 0.45 
2 0.54 31.45 58.36 0.97 0.56 
3 0.57 34.18 60.49 1.01 0.56 
4 0.60 38.80 64.22 1.01 0.59 
5 0.36 13.52 38.09 1.01 0.36 
6 0.76 49.52 64.99 1.31 0.58 
7 0.59 46,46 78.47 1.31 0.45 
8 0.54 29.66 55.13 1.31 0.41 
9 0.55 34,82 63.52 0.99 0.56 
10 0.59 1837 31.13 0.87 0.68 
11 0.53 13.61 25.90 1.40 0.38 
12 0.97 57.72 59.78 1.40 0.69 
13 0.40 15.51 38.81 0.93 0.43 
14 0.56 22.18 39.30 0.93 0.60 
15 0.76 53.59 70.94 1.02 0.74 
16 0.59 28.60 48.20 1.02 0.58 
Mean 0.58 0.54 
SD 0.15 0.11 
Hearts with DCM 
1 0.93 61.12 65.74 0.97 0.96 
2 0.83 38.60 46.59 0.97 0.86 
3 0.80 35.76 44.67 1.01 0.79 
4 0.81 50.47 62.46 1.01 0,80 
5 0.71 34.09 47.95 1.01 0,70 
6 1.1 71.40 64.21 1.31 0,84 
7 1.00 25.76 25.73 1.31 0~76 
8 1.05 29.13 27.80 1.31 0.80 
9 0.98 37.24 38.18 1.31 0.74 
10 1.09 22.82 20.87 1.07 1.02 
11 0.77 18.99 24.72 1.07 0.72 
12 1.03 33.38 32.43 1.07 0.96 
13 1.29 39.13 30.41 0.87 1.48 
14 1.00 24.69 24.98 0.87 1.15 
15 1.37 21.93 15.96 1.40 0.98 
16 1.45 71.10 49.00 1.38 1.05 
17 1.21 81.20 66.90 1.38 0.88 
18 0.90 40.20 44.80 1.38 0.65 
19 1.02 47.5 46.8 1.38 0.73 
Mean 1.12 0.89 
SD 0.20 0.20 
DCM = dilated cardiomyopathy. 
sections were used to measure densitophotometrically the type 
I/type III collagen ratio, which also allowed their identification 
within the tissues (11). The cyanogen bromide analysis was 
performed on consecutive cryostat sections and thus provided 
additional quantitative data. A previous study (4) of heart 
tissue obtained from patients with chronic congestive heart 
failure has shown an increase in type I collagen. However, that 
study (4) was based on a biochemical assay of sampled blocks 
of myocardium and therefore did not allow tissue localization 
of the collagens. Other studies (3,4) using immunostaining 
techniques for both types I and III collagen have shown an 
increase in the staining intensity in the endomysium and 
perimysium of hearts of patients with dilated cardiomyopathy 
but without further quantification. The present study shows 
quantitative data at the light microscopic level, indicating that 
the total collagen increased significantly in hearts with dilated 
cardiomyopathy and that the type I/type III collagen ratio 
increased. Moreover, these increases were found to be local- 
ized in both endomysium and perimysium. These observations 
have been further substantiated by our ultrastructural studies. 
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Figure 4. Fibrous long-spacing collagen (arrows) in the endomysium 
immediately next o a myocyte (M) in a heart with dilated cardiomy- 
opathy. ×37,000. 
Figure 3. Cross ections of an area with packed collagen fibrils that 
show that he overall circumference in reference h arts (A) is less than 
that in hearts with dilated cardiomyopathy (B).Both x50,000. 
Electron microscopic analysis. At the ultrastructural level, 
alterations indistribution of both types of collagen were found. 
The increase in endomysial collagen appears as a diffuse 
Table 3. Number of Collagen Fibrils and Their Circumferences in 
Reference Hearts and Hearts With Dilated Cardiomyopathy 
Average 
No. of Fibrils Circumference* 
Specimen Measured (nm) SD 
Reference hearts 
1 421 121.7 16.9 
2 416 129.7 15.1 
3 4(17 117.8 16.0 
4 411 129.7 15.1 
5 428 105.9 13.8 
6 250 115.9 12.4 
Hearts with DCM 
1 466 143.5 17.6 
2 455 141.0 15.2 
3 309 144.4 14.2 
4 332 140.3 20.6 
5 41)2 146.2 14.1 
6 410 143.6 17.3 
*The differences between reference hearts and hearts with dilated cardio- 
myopathy (DCM) show statistical significance (p < 0.01). 
phenomenon, whereas that in the perimysium was much more 
inhomogeneous. Our immunoelectron microscopic studies also 
show an increase in type I collagen over type III, although 
these observations were not quantified. The increase in type I
collagen is present in both endomysium and perimysium, 
diffusely distributed in the endomysium and patchy in the 
perimysium. This could account for the significant increase in 
collagen fibril circumference in hearts with dilated cardiomy- 
opathy compared with that in reference hearts (Table 3). It has 
been shown (24-26) that the growth in diameter of type I 
collagen is limited by type III collagen. The latter is laid down 
onto a core of type I collagen and thus inhibits further growth. 
It is conceivable, therefore, that a change in the ratio that 
results in the formation of less type III than type I collagen may 
interfere with the regulation of growth of collagen. This would 
result in an increase in thicker fibrils. Our observation of a shift 
toward thick fibrils in hearts with dilated cardiomyopathy could 
result from such a phenomenon, which may be caused by an 
imbalance in either formation or degradation between the two 
types of collagen. The observations by Heneghan et al. (2), who 
also found thicker fibrils in hearts with dilated cardiomyopa- 
thy, could also relate to this phenomenon. However, these 
investigators did not specify the types of collagen involved. 
The occurrence oflong-spacing collagen among endomysial 
collagen fibrils, not reported previously, also focuses on abnor- 
malities in collagen, because long-spacing collagen is consid- 
ered to reflect active degradation fcollagens (27,28). Thus far 
it is uncertain what types of collagen are involved in the 
formation of long-spacing collagen, other than that recent 
studies (29) have shown an association with type VI collagen. 
We have been unable to study type VI collagen at the 
ultrastructural level and, therefore, cannot exclude the possi- 
bility that the long-spacing collagen is indeed type VI. How- 
ever, experimental studies (27,28) using collagenase on dermal 
tissue, which produces long-spacing collagen, strongly suggest 
that other collagen types are also involved. Be that as it may, 
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Figure 5. Immunoelectron micrographs of collagen type I in a reference heart (A) and a heart with dilated cardiomyopathy (C). B and D show 
immunolabeling ofcollagen type III in a reference heart and a heart with dilated cardiomyopathy, respectively. The gold particles are seen as black 
dots. x38,000. 
the finding that reference hearts do not show this phenomenon 
in endomysial sites endorses the concept hat its presence is a 
sign of aberrant collagen turnover. 
Our study shows that hearts with dilated cardiomyopathy 
not only show an increase in collagens but, in fact, present a 
distinct alteration in the composition of the interstitial collagen 
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Figure 6. Immunoelectron microscopic dou- 
ble staining of collagen types I and III in a 
heart with dilated cardiomyopathy. The 
15-nm gold particles represent collagen type 
I; the 30-nm gold particles represent collagen 
type Ill (small and large black dots, respec- 
tively). ×38,000. 
network. It is likely that these structural changes provide the 
substrate for the progressive increase in myocardial stiffness. 
Speculations and mechanisms. The question arises, there- 
fore, as to what mechanisms could be responsible for the 
increase in total collagen and the shift in the type I/type III 
collagen ratio in particular. In this context it is important to 
realize that all end-stage patients received extensive medica- 
tion and that an effect of drugs, therefore, cannot be ruled out. 
This is important also because it is known that a variety of 
substances can affect collagens. For instance, captopril owers 
the total collagen concentration i patients with ischemic 
cardiomyopathy and decreases the type I/type III collagen ratio 
compared with that in untreated patients (30). Experimental 
studies (31,32), moreover, have demonstrated that angiotensin 
II and aldosterone promote the synthesis of collagen in 
cultured fibroblasts. Recently, the regulation of type I collagen 
gene expression by thyroid hormone has been demonstrated 
(33). Human growth hormone may also play a role because the 
incidence of ventricular aneurysms in experimentally induced 
infarcts in animals is markedly reduced when hormones are 
applied, which appears to be related to the preservation of the 
myocardial collagen matrix (34). All these findings uggest that 
pharmacologic and hormonal agents may influence the colla- 
gen framework of the heart, although the mechanisms in 
operation and their possible interactions remain speculative. 
However, one could hypothesize that eventually the medica- 
tion in these patients may no longer be beneficial but rather 
induce deleterious side effects that may cause irreversible heart 
failure. 
It would be of considerable interest, therefore, to know at 
what stage of the disease these changes first appear and to 
evaluate further whether medication may have an effect on the 
increase in collagen and the shift in the type l/type Ill collagen 
ratio. 
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